Annika Anderson
Education
M.P.H., epidemiology, Columbia University Mailman School of Public Health; B.A., chemistry and global health and environment, Washington University in St. Louis
Summary of Experience
Ms. Anderson applies quantitative methods to research questions related to burden of illness, patient outcomes, and health policy. She specializes in RWE generation and the analysis of real-world data, including data sourced from clinical trials, administrative claims, electronic medical records, chart data, and surveys. Ms. Anderson has extensive research and consulting experience in a range of disease areas, including rare diseases, oncology, nephrology, rheumatology, and autoimmune diseases. Her research has been published in numerous peer-reviewed journals and presented at clinical and economic research conferences.
-
Epidemiology and Economic Burden of Diagnosed Congenital Cytomegalovirus Infection in the First 2 Years of Life among Commercially Insured and Medicaid-Insured Individuals in the United States
Clinical Therapeutics, 2025
2025Diaz-Decaro J, Demmler-Harrison GJ, Marden JR, Anderson A, Basnet S, Gaburo K, Kirson N, Desai U, Buck PO
-
Impact of Dry Age-Related Macular Degeneration on Daily Activities and Quality of Life: Interview Findings From Patients and Caregivers Relative to a General Population
Clinical Ophthalmology, 2025
2025Chamberlain CX, Morga A, Song Y, Louise Edwards ML, Anderson A, Sarathy K, Christensen D, Iannaccone A, Su J
-
Retrospective claims analysis of the epidemiology and economic burden of diagnosed congenital cytomegalovirus in Japan
Current Medical Research and Opinion, 2025
2025Buck PO, Goldschmidt D, Anderson A, Kirson N, Desai U, Diaz-Decaro J
-
Healthcare costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective
Blood Advances, 2023
2023Maziarz RT, Gergis U, Edwards ML, Song Y, Liu Q, Anderson A, Signorovitch JE, Manghani R, Simantov R, Shin H, Sivaraman S
-
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: a retrospective study using the SEER-Medicare database
Leukemia Research, 2023
2023Brunner AM, Huggar D, Copher R, Zhou ZY, Zichlin ML, Anderson A, Downes N, McBride A
-
Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey
Advances in Therapy, 2023
2023Toro W, Yang M, Georgieva M, Anderson A, LaMarca N, Patel A, Akbarnejad H, Dabbous O
-
Health Care Resource Utilization by Patients with Alagille Syndrome
The Journal of Pediatrics, 2023
2023Ebel NH, Goldstein A, Howard R, Mogul DB, Marden JR, Anderson A, Gaburo K, Kirson N, Rosenthal P
-
Costs of Pediatric Liver Transplantation among Commercially- and Medicaid-Insured Patients with Cholestasis in the United States
Liver Transplantation, 2023
2023Miloh T, Goldstein A, Howard R, Mogul DB, Marden JR, Anderson A, Gaburo K, Kirson N, Rosenthal P
-
The Economic Burden of Schizophrenia in the United States
Journal of Clinical Psychiatry, 2022
2022Kadakia A, Catillon M, Fan Q, Williams GR, Marden JR, Anderson A, Kirson N, Dembek C
-
Maralixibat Treatment Response in Alagille Syndrome Is Associated with Improved Health-Related Quality of Life
The Journal of Pediatrics, 2022
2022Kamath BM, Goldstein A, Howard R, Garner W, Vig P, Marden JR, Billmyer E, Anderson A, Kirson N, Jacquemin E, Gonzales E